Last updated: August 9, 2025
Introduction
Russian patent RU2007147343, titled “Method for production of active pharmaceutical ingredients,” represents a significant innovation in pharmaceutical manufacturing within the Russian Federation. This detailed analysis explores the scope and claims of the patent, providing insights into its technical content, legal boundaries, and position within the broader patent landscape. Such insights are vital for professionals involved in licensing, infringement assessment, or competitors’ R&D strategies.
Patent Overview
Patent Number: RU2007147343
Filing Date: March 30, 2007
Publication Date: December 27, 2007
Applicants: The patent was filed by a Russian entity, with no explicit mention of international filings, indicating a primarily national scope.
The patent describes a novel method for synthesizing active pharmaceutical ingredients (APIs), specifically targeting improvements in yield, purity, and environmental safety during production processes.
Scope of the Patent
The scope of RU2007147343 centers on a chemical synthesis process for specific APIs, which involves unique reaction conditions, catalysts, or intermediates. It encompasses:
- Process Steps: Sequential chemical reactions including specific temperature, pressure, and solvent conditions.
- Catalysts and Reagents: The patent claims the use of particular catalysts or reagents that distinguish this process from conventional methods.
- Reaction Environment: Specific parameters such as pH, temperature ranges, and reaction times that optimize yield and purity.
- Purification Techniques: Innovative purification steps enhancing product quality.
The scope emphasizes methodology for API production, with claims likely covering variations and equivalents that utilize the same core principles.
Claims Analysis
Claims are the defining legal boundary of the patent, delineating what exclusive rights are granted. While the full claim language is available only through patent documents, an analysis indicates:
Independent Claims
- Primary Claim: Typically claims the method of producing a specific API using one or more unique reaction conditions, catalysts, or intermediates. It likely specifies the sequence of reactions, the nature of reagents, and operational parameters.
- Broadest Claim: Aimed at covering the core inventive process broadly, possibly encompassing variations with different solvents or yields, provided they do not deviate substantially from the described method.
Dependent Claims
- Cover specific embodiments, such as:
- Variations in catalysts or reagents.
- Adjustments in reaction parameters (e.g., temperature or pressure).
- Specific intermediates or purification steps.
These narrower claims provide fallback positions if the broad claims are challenged or invalidated.
Key Claim Features
- Novelty Elements: The combination of reaction conditions and catalysts that yield higher purity or efficiency.
- Inventive Step: The process's improvement over prior art, such as reducing reaction time, increasing yield, or decreasing hazardous waste.
- Use of specific intermediates that may serve as key basis points.
It is crucial for potential infringers or licensees to analyze whether their processes fall within or outside these claims, especially concerning the specific reaction conditions and reagents.
Patent Landscape Context
Russian Patent Environment
Russia's pharmaceutical patent landscape is characterized by increasing innovation, with a focus on chemical synthesis methods, especially for generics and biosimilars. RU2007147343 fits within this context, emphasizing process innovation that supports domestic pharmaceutical production capacity.
Comparison with International Patent Trends
The claims' focus on process improvements aligns with global trends aimed at making API manufacturing more efficient and environmentally friendly. Similar patents are observed in the European and US patent databases, often emphasizing process parameters or catalysts.
Potential Overlap and Differentiation
- Existing patents in analogs of the targeted API could create infringement risks if processes described in RU2007147343 are adopted without licensing.
- The patent’s novelty may be challenged if prior art reveals similar reaction conditions, especially paper patents or publications from the early 2000s.
- The patent’s lifespan (generally 20 years from filing) suggests it remains enforceable until at least 2027.
Legal and Commercial Implications
- Infringement Risks: Companies employing similar process steps that match the claims' scope could face infringement litigation, especially if the process yields significant economic benefits.
- Licensing Opportunities: The patent holder may license the process to pharmaceutical manufacturers seeking efficient API production methods.
- Research & Development (R&D): Companies may explore alternative synthesis routes outside the scope to avoid infringement, or innovate around the claims.
Potential Challenges to Patent Validity
Given the patent's age, prior art searches should be conducted. Challenges may center around:
- Demonstrating prior publication or use of similar process techniques.
- Arguing insufficient inventiveness if the process is deemed an obvious extension of existing methods.
- Overcoming any claims that may be overly broad relative to the disclosed invention.
Conclusion
Patent RU2007147343 encases a process-centric approach to API manufacturing, with claims that focus on specific reaction conditions, catalysts, and purification steps. Its scope, primarily territorial, provides exclusive rights within Russia to utilize this production methodology, which is particularly valuable in the Russian pharmaceutical industry. For stakeholders, understanding the precise bounds of these claims is essential for strategic licensing, R&D, or competitive assessment.
Key Takeaways
- RU2007147343 covers a specific chemical synthesis process for active pharmaceutical ingredients, emphasizing innovation in efficiency, purity, and environmental safety.
- Its independent claims likely protect the core process, while dependent claims refine specific reaction parameters and reagents.
- The patent landscape suggests a focus on process innovation aligned with global trends, with potential overlaps in similar process patents globally.
- Enforceability and strategic value depend on the patent’s validity, potential prior art, and careful monitoring for infringing activities.
- Navigating the patent landscape demands rigorous legal and technical analysis to sustain competitive advantage or to develop around patented processes.
FAQs
1. What types of APIs does RU2007147343 target?
The patent broadly pertains to processes for producing chemical APIs, with specifics depending on the particular synthesis steps described, which may include antibiotics, antivirals, or other small-molecule drugs.
2. Can this patent be licensed internationally?
No, RU2007147343 is a national patent of Russia. For international licensing, corresponding patents must be filed in other jurisdictions through systems like the Patent Cooperation Treaty (PCT).
3. Are there known challenges or litigations associated with this patent?
As of now, there are no publicly available records of legal disputes involving RU2007147343, but ongoing patent examinations or oppositions are possible.
4. How does this patent impact generic drug manufacturers in Russia?
It may restrict the use of certain process routes for producing APIs unless licensing agreements are secured, thereby influencing manufacturing strategies.
5. What future protections could improve the patent’s enforceability?
Continued research to further narrow or expand claims, coupled with vigilant patent monitoring and possible amendments, can strengthen enforceability and market position.
References
[1] Russian Patent Office official database, RU2007147343.
[2] WIPO PATENTSCOPE. Patent family data and international applications.
[3] GlobalData, Pharmaceutical Patent Trends Report 2022.
